These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30827343)

  • 1. Emerging In Vitro Systems to Screen and Predict Drug-Induced Kidney Toxicity.
    Nieskens TTG; Sjögren AK
    Semin Nephrol; 2019 Mar; 39(2):215-226. PubMed ID: 30827343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization-Dependent Cisplatin Toxicity.
    Nieskens TTG; Persson M; Kelly EJ; Sjögren AK
    Drug Metab Dispos; 2020 Dec; 48(12):1303-1311. PubMed ID: 33020068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney-on-a-chip technology for renal proximal tubule tissue reconstruction.
    Nieskens TT; Wilmer MJ
    Eur J Pharmacol; 2016 Nov; 790():46-56. PubMed ID: 27401035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Culture Models of AKI: From Tubule Cells to Human Kidney Organoids.
    Bejoy J; Qian ES; Woodard LE
    J Am Soc Nephrol; 2022 Mar; 33(3):487-501. PubMed ID: 35031569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models.
    D'Costa K; Kosic M; Lam A; Moradipour A; Zhao Y; Radisic M
    Ann Biomed Eng; 2020 Jul; 48(7):2002-2027. PubMed ID: 32285341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery.
    Boreström C; Jonebring A; Guo J; Palmgren H; Cederblad L; Forslöw A; Svensson A; Söderberg M; Reznichenko A; Nyström J; Patrakka J; Hicks R; Maresca M; Valastro B; Collén A
    Kidney Int; 2018 Dec; 94(6):1099-1110. PubMed ID: 30072040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell- and biomarker-based assays for predicting nephrotoxicity.
    Huang JX; Blaskovich MA; Cooper MA
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1621-35. PubMed ID: 25382677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model.
    Astashkina AI; Jones CF; Thiagarajan G; Kurtzeborn K; Ghandehari H; Brooks BD; Grainger DW
    Biomaterials; 2014 Aug; 35(24):6323-31. PubMed ID: 24814424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells.
    Li Y; Kandasamy K; Chuah JK; Lam YN; Toh WS; Oo ZY; Zink D
    Mol Pharm; 2014 Jul; 11(7):1982-90. PubMed ID: 24495215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines.
    Astashkina AI; Mann BK; Prestwich GD; Grainger DW
    Biomaterials; 2012 Jun; 33(18):4712-21. PubMed ID: 22475530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing.
    Chen WY; Evangelista EA; Yang J; Kelly EJ; Yeung CK
    Front Pharmacol; 2021; 12():695920. PubMed ID: 34381363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology.
    Schutgens F; Verhaar MC; Rookmaaker MB
    Eur J Pharmacol; 2016 Nov; 790():12-20. PubMed ID: 27375081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney on chips.
    Lee J; Kim K; Kim S
    Methods Cell Biol; 2018; 146():85-104. PubMed ID: 30037468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of hepatocyte-like cells to enhance hepatic safety risk assessment in drug discovery.
    Williams DP
    Philos Trans R Soc Lond B Biol Sci; 2018 Jul; 373(1750):. PubMed ID: 29786562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment.
    Jang KJ; Mehr AP; Hamilton GA; McPartlin LA; Chung S; Suh KY; Ingber DE
    Integr Biol (Camb); 2013 Sep; 5(9):1119-29. PubMed ID: 23644926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in predictive in vitro models of drug-induced nephrotoxicity.
    Soo JY; Jansen J; Masereeuw R; Little MH
    Nat Rev Nephrol; 2018 Jun; 14(6):378-393. PubMed ID: 29626199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model.
    Diekjürgen D; Grainger DW
    Pflugers Arch; 2018 Sep; 470(9):1311-1323. PubMed ID: 29744639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening.
    Wilmer MJ; Ng CP; Lanz HL; Vulto P; Suter-Dick L; Masereeuw R
    Trends Biotechnol; 2016 Feb; 34(2):156-170. PubMed ID: 26708346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.